Salud financiera de hoja de balance de Sacyr

Salud financiera controles de criterios 4/6

Sacyr tiene un patrimonio de accionistas total de €1.8B y una deuda total de €8.5B, lo que sitúa su ratio deuda-patrimonio en 487.1%. Sus activos y pasivos totales son €17.3B y €15.6B respectivamente. El BAIT de Sacyr es de €1.3B, por lo que su ratio de cobertura de intereses es de 1.7. Tiene efectivo e inversiones a corto plazo que ascienden a €1.8B.

Información clave

487.1%

Ratio deuda-patrimonio

€8.52b

Deuda

Ratio de cobertura de intereses1.7x
Efectivo€1.77b
Patrimonio€1.75b
Total pasivo€15.56b
Activos totales€17.31b

Actualizaciones recientes sobre salud financiera

Recent updates

Sacyr (BME:SCYR) Use Of Debt Could Be Considered Risky

Apr 18
Sacyr (BME:SCYR) Use Of Debt Could Be Considered Risky

Is There Now An Opportunity In Sacyr, S.A. (BME:SCYR)?

Mar 06
Is There Now An Opportunity In Sacyr, S.A. (BME:SCYR)?

What Does Sacyr, S.A.'s (BME:SCYR) Share Price Indicate?

Sep 08
What Does Sacyr, S.A.'s (BME:SCYR) Share Price Indicate?

Does Sacyr (BME:SCYR) Have A Healthy Balance Sheet?

Aug 18
Does Sacyr (BME:SCYR) Have A Healthy Balance Sheet?

Sacyr (BME:SCYR) Takes On Some Risk With Its Use Of Debt

May 11
Sacyr (BME:SCYR) Takes On Some Risk With Its Use Of Debt

Is It Too Late To Consider Buying Sacyr, S.A. (BME:SCYR)?

Mar 22
Is It Too Late To Consider Buying Sacyr, S.A. (BME:SCYR)?

Sacyr (BME:SCYR) Has A Somewhat Strained Balance Sheet

Feb 10
Sacyr (BME:SCYR) Has A Somewhat Strained Balance Sheet

Is Sacyr, S.A. (BME:SCYR) Trading At A 29% Discount?

Dec 01
Is Sacyr, S.A. (BME:SCYR) Trading At A 29% Discount?

Sacyr, S.A. (BME:SCYR) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Nov 10
Sacyr, S.A. (BME:SCYR) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Sacyr (BME:SCYR) Has A Somewhat Strained Balance Sheet

Aug 02
Sacyr (BME:SCYR) Has A Somewhat Strained Balance Sheet

Sacyr's (BME:SCYR) Upcoming Dividend Will Be Larger Than Last Year's

Jun 02
Sacyr's (BME:SCYR) Upcoming Dividend Will Be Larger Than Last Year's

Is Sacyr (BME:SCYR) A Risky Investment?

Oct 19
Is Sacyr (BME:SCYR) A Risky Investment?

Does Sacyr (BME:SCYR) Have A Healthy Balance Sheet?

Jul 14
Does Sacyr (BME:SCYR) Have A Healthy Balance Sheet?

Robust Earnings May Not Tell The Whole Story For Sacyr (BME:SCYR)

Mar 06
Robust Earnings May Not Tell The Whole Story For Sacyr (BME:SCYR)

An Intrinsic Calculation For Sacyr, S.A. (BME:SCYR) Suggests It's 41% Undervalued

Feb 19
An Intrinsic Calculation For Sacyr, S.A. (BME:SCYR) Suggests It's 41% Undervalued

How Many Sacyr, S.A. (BME:SCYR) Shares Do Institutions Own?

Jan 20
How Many Sacyr, S.A. (BME:SCYR) Shares Do Institutions Own?

Have Insiders Been Selling Sacyr, S.A. (BME:SCYR) Shares?

Dec 24
Have Insiders Been Selling Sacyr, S.A. (BME:SCYR) Shares?

What Type Of Returns Would Sacyr's(BME:SCYR) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Dec 02
What Type Of Returns Would Sacyr's(BME:SCYR) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (€6.9B) de SCYR superan a sus pasivos a corto plazo (€6.3B).

Pasivo a largo plazo: Los activos a corto plazo (€6.9B) de SCYR no cubren sus pasivos a largo plazo (€9.2B).


Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de SCYR (385.9%) se considera alta.

Reducción de la deuda: El ratio deuda-patrimonio de SCYR ha pasado de 517.1% a 487.1% en los últimos 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: Aunque no es rentable SCYR tiene suficiente cash runway para más de 3 años si mantiene su actual nivel positivo de flujo de caja libre.

Pronóstico de cash runway: SCYR no es rentable pero tiene suficiente cash runway para más de 3 años, debido a que el flujo de caja libre es positivo y crece un 15% al año.


Descubre empresas con salud financiera

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target